Integrative study of lung cancer adeno-to-squamous transition in EGFR TKI resistance identifies RAPGEF3 as a therapeutic target
Hua Wang(Chinese Academy of Sciences), Hongbin Ji(Westlake University), Kwok‐Kin Wong(NYU Langone Health), Qibiao Wu(Macau University of Science and Technology), Xinyuan Tong(Chinese Academy of Sciences), Chenchen Guo(Shanghai Chest Hospital), Shijie Tang(Chinese Academy of Sciences), Weikang Zhu(Chinese Academy of Sciences), Shun Yao(Chinese Academy of Sciences), Yayi He(Helix (United States)), Cai‐Guang Yang(Chinese Academy of Sciences), Xinyun Xie(Chinese Academy of Sciences), Shuo Han(Chinese Academy of Sciences), Zhen Qin(Chinese Academy of Sciences), Xiaoling Xu(Tongji University), Yueh‐Hung Chou(Far Eastern Memorial Hospital), Shiyu Zhou(Institute of High Energy Physics), Xue Wang(Chinese Academy of Sciences), Yong Wang(Guiyang Medical University), Liang Hu(Ministry of Agriculture and Rural Affairs), Luonan Chen(Shanghai Jiao Tong University)
Cited by 7
Related Papers
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
|Nature Medicine|2008|1.3k
A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
|Cell|2009|1k
High-throughput oncogene mutation profiling in human cancer
|Nature Genetics|2007|996
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
|Nature Genetics|2018|701